LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Yankee Pitcher’s Knee Gets Stem Cell Shots
Large Joints and Extremities

Yankee Pitcher’s Knee Gets Stem Cell Shots

June 4, 2014 1 min read Premium comments

Advertisement

Yankee Pitcher’s Knee Gets Stem Cell Shots
C.C. Sabathia/Wikimedia Commons and Chris Ptacek
Secondary

New York Yankees pitcher C.C. Sabathia received a stem cell injection in his right knee to deal with a degenerative condition in the cartilage. James Andrews, M.D., told the Yankees that the repair to the knee would take a minimum of six weeks if it works.

Yankees General Manager Brian Cashman is quoted by writer Del Veddhio as saying, “Our dialogue with Andrews has been good and given the small sample of stem cell procedures, the results are very successful. But he has to be pain free before strengthening, so there is a way to go. Because he is a starter it will take longer. I have no idea how long it will be and if it will be successful. We are hoping it is six weeks to a major league return.”

Sabathia is the highest-paid pitcher in Major League Baseball (MLB) history. Currently in his 13th year as a major league pitcher, Sabathia has never had more losses than wins in a season. Sabathia played the first seven and a half seasons of his career with the Cleveland Indians, where he won the 2007 Cy Young Award. He played the second half of the 2008 MLB season with the Milwaukee Brewers, leading them to the Wild Card, their first playoff appearance in 26 years. Sabathia is regarded as one of the most durable pitchers in Major League Baseball, having averaged over 200 innings pitched per season during his career.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy